Namodenoson
CF102-212LD
Phase 2 small_molecule active
Quick answer
Namodenoson for NASH - Nonalcoholic Steatohepatitis is a Phase 2 program (small_molecule) at Can-Fite BioPharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Can-Fite BioPharma
- Indication
- NASH - Nonalcoholic Steatohepatitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active